At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NUVB Nuvation Bio, Inc.
Not Yet Opened 06-03 16:00:00 EDT
4.72
-0.18
-3.67%
盘后4.65
-0.07-1.48%
19:48 EDT
High4.85Low4.59Vol3.23M
Open4.85D1 Closing4.90Amplitude5.31%
Mkt Cap1.64BTradable Cap1.09BTotal Shares347.60M
T/O15.13MT/O Rate1.40%Tradable Shares231.05M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Did New IBTROZI Quality‑of‑Life Data Just Shift Nuvation Bio’s (NUVB) Investment Narrative?
Simply Wall St.  ·  05-29
Did New IBTROZI Quality‑of‑Life Data Just Shift Nuvation Bio’s (NUVB) Investment Narrative?
Nuvation Bio held annual shareholder meeting
Reuters  ·  05-28
Nuvation Bio held annual shareholder meeting
Nuvation Bio to present at Jefferies Global Healthcare Conference fireside chat
Reuters  ·  05-28
Nuvation Bio to present at Jefferies Global Healthcare Conference fireside chat
Nuvation Bio’s Ibtrozi shows improved quality of life in NSCLC trial
TIPRANKS  ·  05-27
Nuvation Bio’s Ibtrozi shows improved quality of life in NSCLC trial
Nuvation Bio to present TRUST-II quality-of-life data for IBTROZI in ROS1+ lung cancer at ASCO 2026
Reuters  ·  05-27
Nuvation Bio to present TRUST-II quality-of-life data for IBTROZI in ROS1+ lung cancer at ASCO 2026
H.C. Wainwright Reaffirms Their Buy Rating on Nuvation Bio (NUVB)
TIPRANKS  ·  05-27
H.C. Wainwright Reaffirms Their Buy Rating on Nuvation Bio (NUVB)
Analysts Are Bullish on Top Healthcare Stocks: Nuvation Bio (NUVB), Universal Health (UHS)
TIPRANKS  ·  05-26
Analysts Are Bullish on Top Healthcare Stocks: Nuvation Bio (NUVB), Universal Health (UHS)
How Does Nuvation Bio’s (NUVB) IBTROZI Update Reframe Its Long-Term Oncology Investment Narrative?
Simply Wall St.  ·  05-20
How Does Nuvation Bio’s (NUVB) IBTROZI Update Reframe Its Long-Term Oncology Investment Narrative?
Nuvation Bio collaborating with Thermo Fisher to manufacture Ibtrozi in NSCLC
TIPRANKS  ·  05-14
Nuvation Bio collaborating with Thermo Fisher to manufacture Ibtrozi in NSCLC
Nuvation Bio partners with Thermo Fisher for US manufacturing of IBTROZI
Reuters  ·  05-14
Nuvation Bio partners with Thermo Fisher for US manufacturing of IBTROZI
Nuvation Bio to Collaborate With Thermo Fisher Scientific for U.S.-Based Manufacturing of Ibtrozi® for Ros1-Positive Non-Small Cell Lung Cancer
THOMSON REUTERS  ·  05-14
Nuvation Bio to Collaborate With Thermo Fisher Scientific for U.S.-Based Manufacturing of Ibtrozi® for Ros1-Positive Non-Small Cell Lung Cancer
Nuvation Bio says FDA accepts IBTROZI label update filing for ROS1+ NSCLC
Reuters  ·  05-06
Nuvation Bio says FDA accepts IBTROZI label update filing for ROS1+ NSCLC
Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for Ibtrozi® (Taletrectinib) With Updated Duration of Response in Advanced Ros1-Positive Non-Small Cell Lung Cancer
THOMSON REUTERS  ·  05-06
Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for Ibtrozi® (Taletrectinib) With Updated Duration of Response in Advanced Ros1-Positive Non-Small Cell Lung Cancer
Nuvation Bio Inc - FDA Accepts Supplemental Nda for Ibtrozi in Advanced Ros1+ Nsclc; Target Action Date Jan 4, 2027
THOMSON REUTERS  ·  05-06
Nuvation Bio Inc - FDA Accepts Supplemental Nda for Ibtrozi in Advanced Ros1+ Nsclc; Target Action Date Jan 4, 2027
Nuvation Bio participates in Bank of America Securities Healthcare Conference fireside chat
Reuters  ·  05-06
Nuvation Bio participates in Bank of America Securities Healthcare Conference fireside chat
Stock Track | Nuvation Bio Soars 5.33% Intraday on Positive Analyst Coverage and Maintained Price Targets
Stock Track  ·  05-05
Stock Track | Nuvation Bio Soars 5.33% Intraday on Positive Analyst Coverage and Maintained Price Targets
Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT), Evolus (EOLS) and Nuvation Bio (NUVB)
TIPRANKS  ·  05-05
Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT), Evolus (EOLS) and Nuvation Bio (NUVB)
Nuvation Bio Price Target Maintained With a $17.00/Share by HC Wainwright & Co.
Dow Jones  ·  05-05
Nuvation Bio Price Target Maintained With a $17.00/Share by HC Wainwright & Co.
Earnings Flash (NUVB) Nuvation Bio Posts Q1 EPS $0.01, vs. FactSet Est of $0.03 Loss
MT Newswires Live  ·  05-05
Earnings Flash (NUVB) Nuvation Bio Posts Q1 EPS $0.01, vs. FactSet Est of $0.03 Loss
Nuvation Bio publishes corporate presentation on IBTROZI ROS1 lung cancer drug```
Reuters  ·  05-05
Nuvation Bio publishes corporate presentation on IBTROZI ROS1 lung cancer drug```

Introduction

Company Name.
Nuvation Bio, Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung , M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco .
Issue price:
--